Form D — SLAM BioTherapeutics, Inc.
0002014118-25-000002 · filed Mar 3, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $10,000,000
- Total sold
- $500,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- SLAM BioTherapeutics, Inc.
- CIK
- 1983523
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 2945 TOWNSGATE RD., SUITE 200
WESTLAKE VILLAGE, CA 91361 - Phone
- 617-513-4934
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Richard Heinick · Executive OfficerThousand Oaks, CA Find on LinkedIn ↗
-
Steve Potts · Executive OfficerThousand Oaks, CA Find on LinkedIn ↗
-
Mark Hagler · DirectorThousand Oaks, CA Find on LinkedIn ↗
-
David Vennettilli · DirectorThousand Oaks, CA Find on LinkedIn ↗
-
Theodore Schwartz · DirectorThousand Oaks, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗